Impact of concomitant cardiac valvular surgery during implantation of continuous-flow left ventricular assist devices: A European registry for patients with mechanical circulatory support (EUROMACS) analysis.
Antonino LoforteTheo M M H de ByGregorio GliozziFelix SchönrathCarlo MarianiIvan NetukaYuriy PyaDaniel ZimpferGiulio Giovanni CavalliJan GummertBart MeynsDavide PaciniEvgenij Potapovnull nullPublished in: Artificial organs (2021)
The effect of additive valvular procedures (CCPs) does not seem to affect short-term survival, significantly, based on our registry data analysis. However, the decision to perform CCPs should be balanced with the projected type of surgery and preoperative characteristics. LVAD+CCP patients remain a delicate population and adverse device-related events should be strictly monitored and managed.
Keyphrases
- data analysis
- left ventricular
- minimally invasive
- coronary artery bypass
- end stage renal disease
- atrial fibrillation
- chronic kidney disease
- newly diagnosed
- ejection fraction
- heart failure
- aortic valve
- patients undergoing
- prognostic factors
- surgical site infection
- climate change
- mitral valve
- aortic stenosis
- decision making
- left ventricular assist device